Successful treatment of chronic migraine unresponsive to triptans with herbal medicines containing Cinnamomi Cortex: A case report

IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE
Han-Gyul Lee , Seungwon Kwon , Hirozo Goto , Makoto Fujimoto , Mosaburo Kainuma , Ki-Ho Cho
{"title":"Successful treatment of chronic migraine unresponsive to triptans with herbal medicines containing Cinnamomi Cortex: A case report","authors":"Han-Gyul Lee ,&nbsp;Seungwon Kwon ,&nbsp;Hirozo Goto ,&nbsp;Makoto Fujimoto ,&nbsp;Mosaburo Kainuma ,&nbsp;Ki-Ho Cho","doi":"10.1016/j.explore.2025.103115","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Migraine is a neurological disorder characterized by severe, unilateral, pulsating headaches with visual, olfactory, and auditory hypersensitivity, as well as autonomic symptoms. Currently, triptans are the standard treatment, but they often fail to relieve symptoms. Herbal medicines are alternative treatments to overcome these limitations.</div></div><div><h3>Case presentation</h3><div>A 73-year-old Asian man visited our hospital with a 5-year history of headache and pulsation of blood vessels in the left temple. He had been using sumatriptan for three years, but it was ineffective. Based on the International Classification of Headache Disorders, 3rd edition (ICHD-3), he was diagnosed with migraine without aura. The herbal medicines Gyejigayonggolmoryeo-tang (GYT) and Shihogayonggolmoryeo-tang (SYT), both of which contain Cinnamomi Cortex, were prescribed. Forty-two days after starting herbal medicine treatment, the numeric rating scale (NRS) score decreased from 10 to 5, and the frequency of migraine attacks decreased from four times to once weekly. On day 97, the NRS score further improved to 3; therefore, SYT was discontinued. Oreongsan (ORS), an herbal medicine containing Cinnamomi Cortex, was administered only during pain attacks. On day 146, the pain almost disappeared, with an NRS score of 2, and only ORS was prescribed. On day 188, the patient was pain-free without ORS. At the last follow-up (day 456), the patient reported no recurrence of symptoms.</div></div><div><h3>Conclusions</h3><div>Here, we describe a male patient with migraine symptoms unresponsive to triptans who experienced improvement shortly after using herbal medicines containing Cinnamomi Cortex. Therefore, these may be an appropriate alternative to triptans for treating migraine.</div></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"21 2","pages":"Article 103115"},"PeriodicalIF":1.9000,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Explore-The Journal of Science and Healing","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1550830725000060","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Migraine is a neurological disorder characterized by severe, unilateral, pulsating headaches with visual, olfactory, and auditory hypersensitivity, as well as autonomic symptoms. Currently, triptans are the standard treatment, but they often fail to relieve symptoms. Herbal medicines are alternative treatments to overcome these limitations.

Case presentation

A 73-year-old Asian man visited our hospital with a 5-year history of headache and pulsation of blood vessels in the left temple. He had been using sumatriptan for three years, but it was ineffective. Based on the International Classification of Headache Disorders, 3rd edition (ICHD-3), he was diagnosed with migraine without aura. The herbal medicines Gyejigayonggolmoryeo-tang (GYT) and Shihogayonggolmoryeo-tang (SYT), both of which contain Cinnamomi Cortex, were prescribed. Forty-two days after starting herbal medicine treatment, the numeric rating scale (NRS) score decreased from 10 to 5, and the frequency of migraine attacks decreased from four times to once weekly. On day 97, the NRS score further improved to 3; therefore, SYT was discontinued. Oreongsan (ORS), an herbal medicine containing Cinnamomi Cortex, was administered only during pain attacks. On day 146, the pain almost disappeared, with an NRS score of 2, and only ORS was prescribed. On day 188, the patient was pain-free without ORS. At the last follow-up (day 456), the patient reported no recurrence of symptoms.

Conclusions

Here, we describe a male patient with migraine symptoms unresponsive to triptans who experienced improvement shortly after using herbal medicines containing Cinnamomi Cortex. Therefore, these may be an appropriate alternative to triptans for treating migraine.
用含有肉桂皮质的草药成功治疗对曲坦类药物无反应的慢性偏头痛:一例报告。
背景:偏头痛是一种神经系统疾病,其特征是严重的单侧搏动性头痛,伴有视觉、嗅觉和听觉超敏反应,以及自主神经症状。目前,曲坦类药物是标准的治疗方法,但它们往往不能缓解症状。草药是克服这些局限性的替代疗法。病例介绍:一名73岁亚洲男性以5年头痛及左太阳穴血管搏动就诊。他服用舒马他坦已经三年了,但是没有效果。根据国际头痛疾病分类第三版(ICHD-3),诊断为无先兆偏头痛。处方中均含有肉桂皮的中药“气脊加勇高moryeo汤”和“石煤加勇高moryeo汤”。开始中药治疗42天后,数值评定量表(NRS)评分从10分降至5分,偏头痛发作频率从每周4次降至每周一次。第97天,NRS评分进一步提高至3分;因此,SYT停止了。只有在疼痛发作时才服用含有肉桂皮的草药“Oreongsan”(ORS)。第146天,疼痛几乎消失,NRS评分为2分,仅开ORS。第188天,患者无疼痛,无ORS。在最后一次随访(第456天)时,患者报告无症状复发。结论:在这里,我们描述了一位男性偏头痛患者对曲坦类药物无反应,在使用含有肉桂皮质的草药后不久就得到了改善。因此,这些可能是治疗偏头痛的合适替代曲坦类药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Explore-The Journal of Science and Healing
Explore-The Journal of Science and Healing 医学-全科医学与补充医学
CiteScore
3.00
自引率
8.30%
发文量
179
审稿时长
25 days
期刊介绍: EXPLORE: The Journal of Science & Healing addresses the scientific principles behind, and applications of, evidence-based healing practices from a wide variety of sources, including conventional, alternative, and cross-cultural medicine. It is an interdisciplinary journal that explores the healing arts, consciousness, spirituality, eco-environmental issues, and basic science as all these fields relate to health.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信